SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and regulatory …
Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program
SAN FRANCISCO, CA, Jan 11, 2023 – (ACN Newswire via SEAPRWire.com) – More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady …
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate
HONG KONG, Jan 10, 2023 – (ACN Newswire via SEAPRWire.com) – China Biotech Services Holdings Limited (the “Group”; stock code: 8037. HK) has announced that …
Novotech 是 Biotech Showcase 2023 的金牌赞助商
SYDNEY, AU, Dec 20, 2022 – (亚太商讯 via SEAPRWire.com) – 以亚太地区为中心的生物技术专家 CRO Novotech很荣幸成为 Biotech Showcase 202…
Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing
HONG KONG, Dec 9, 2022 – (ACN Newswire via SEAPRWire.com) – Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as “GS Biotech”) officially …
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
SYDNEY, AU, Oct 17, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar …
Avance Clinical Wins International Health Award for Biotech CRO Services
SYDNEY, AU, Sep 28, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South …
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
ADELAIDE, AUS, Aug 29, 2022 – (ACN Newswire via SEAPRWire.com) – Avance Clinical, the leading Australian CRO for international biotechs, is sponsoring two awards – …
Actual net profit exceeds FY2020’s level, China Biotech Services’ (08037) new growth drivers expected to erupt consecutively
HONG KONG, Apr 20, 2022 – (ACN Newswire via SEAPRWire.com) – As the pandemic continued to affect the market, China Biotech Services (08037), which owns …
AMDL, a Subsidiary of China Biotech Services, is Exclusively Licensed to Distribute FDA Approved Lung & Colon Cancer Companion Diagnostic Assay in Several Asian Regions Including China
HONG KONG, Aug 10, 2021 – (ACN Newswire via SEAPRWire.com) – China Biotech Services Holdings Limited (“CH BIOTECH SER ” or “Company”, stock code: 8037.HK) …